Tokyo Tape
Sign in
← Kaken Pharmaceutical

Quarterly report · Q3

4521.TEDINET S100SS78
Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥54.7bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥73.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥55.6bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥8.9bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥12.4bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥9.3bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥8.7bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥13.0bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥9.2bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥12.6bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥6.7bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥9.1bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥6.7bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥9.1bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥168.3bnat 2023-12-31Cons.Assets
Total assets¥166.3bnat 2023-03-31Cons.Assets
Total assets¥167.8bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥28.2bnat 2023-12-31Cons.Liabilities
Total liabilities¥29.5bnat 2023-03-31Cons.Liabilities
Net assets / equity¥140.1bnat 2023-12-31Cons.Net assets
Net assets / equity¥136.8bnat 2023-03-31Cons.Net assets
Net assets / equity¥140.7bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥51.5bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥59.6bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥177.12023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥68.852023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥144.82022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥243.312022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥84.992022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio83.2%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio81.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio83.5%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q3r_E00935-000Medicinereportable segmentrevenue2023-04-01 → 2023-12-31¥52.9bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentrevenue external2023-04-01 → 2023-12-31¥52.9bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentsegment profit2023-04-01 → 2023-12-31¥7.9bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentrevenue2023-04-01 → 2023-12-31¥1.8bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentrevenue external2023-04-01 → 2023-12-31¥1.8bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentsegment profit2023-04-01 → 2023-12-31¥1.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥54.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥54.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥8.9bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentrevenue2022-04-01 → 2022-12-31¥53.8bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentrevenue external2022-04-01 → 2022-12-31¥53.8bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentsegment profit2022-04-01 → 2022-12-31¥11.4bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentrevenue2022-04-01 → 2022-12-31¥1.8bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentrevenue external2022-04-01 → 2022-12-31¥1.8bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentsegment profit2022-04-01 → 2022-12-31¥960m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥55.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥55.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥12.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 380
ItemContextValueUnit
Salaries sgaPrior1YTDDuration4211000000JPY
Salaries sgaCurrentYTDDuration4224000000JPY
Bonuses and provision for bonuses sgaPrior1YTDDuration909000000JPY
Bonuses and provision for bonuses sgaCurrentYTDDuration843000000JPY
Retirement benefit expenses sgaPrior1YTDDuration256000000JPY
Retirement benefit expenses sgaCurrentYTDDuration204000000JPY
Research and development expenses sgaPrior1YTDDuration6310000000JPY
Research and development expenses sgaCurrentYTDDuration8502000000JPY
Other sgaPrior1YTDDuration6480000000JPY
Other sgaCurrentYTDDuration7211000000JPY
Selling general and administrative expensesPrior1YTDDuration18168000000JPY
Selling general and administrative expensesCurrentYTDDuration20986000000JPY
Operating incomePrior1YTDDuration12394000000JPY
Operating incomeCurrentYTDDuration8873000000JPY
Interest income noiPrior1YTDDuration5000000JPY
Interest income noiCurrentYTDDuration6000000JPY
Dividends income noiPrior1YTDDuration428000000JPY
Dividends income noiCurrentYTDDuration466000000JPY
Subsidy income noiPrior1YTDDuration114000000JPY
Subsidy income noiCurrentYTDDuration－JPY
Other noiPrior1YTDDuration52000000JPY
Other noiCurrentYTDDuration49000000JPY
Non operating incomePrior1YTDDuration600000000JPY
Non operating incomeCurrentYTDDuration522000000JPY
Interest expenses noePrior1YTDDuration12000000JPY
Interest expenses noeCurrentYTDDuration13000000JPY
Foreign exchange losses noePrior1YTDDuration1000000JPY
Foreign exchange losses noeCurrentYTDDuration61000000JPY
Other noePrior1YTDDuration4000000JPY
Other noeCurrentYTDDuration17000000JPY
Non operating expensesPrior1YTDDuration18000000JPY
Non operating expensesCurrentYTDDuration92000000JPY
Ordinary incomePrior1YTDDuration12976000000JPY
Ordinary incomeCurrentYTDDuration9304000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration2000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration0JPY
Gain on sales of investment securities eiPrior1YTDDuration1000000JPY
Gain on sales of investment securities eiCurrentYTDDuration4000000JPY
Extraordinary incomePrior1YTDDuration4000000JPY
Extraordinary incomeCurrentYTDDuration5000000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration34000000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration88000000JPY
Impairment loss elPrior1YTDDuration304000000JPY
Impairment loss elCurrentYTDDuration－JPY
Other elPrior1YTDDuration－JPY
Other elCurrentYTDDuration0JPY
Extraordinary lossPrior1YTDDuration338000000JPY
Extraordinary lossCurrentYTDDuration89000000JPY
Income before income taxesPrior1YTDDuration12641000000JPY
Income before income taxesCurrentYTDDuration9220000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass